Table 1 |
||||||||||||||||||||
|
Clinicopathological, immunohistochemistry and FISH results of GC samples. |
||||||||||||||||||||
|
FISH chr17/TP53 (%) |
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Case |
Age |
Sex |
Loc† |
pTNM‡ |
LC§ |
IHC |
2/2 |
2/1 |
1/1 |
3/2 |
3/1 |
3/3 |
4/2 |
4/1 |
1/2 |
2/3 |
4/4 |
4/3 |
5/4 |
2/4 |
|
|
||||||||||||||||||||
|
1 |
77 |
M |
An |
T2N1Mx |
Int |
+ |
77.5 |
11.0 |
10.0 |
1.0 |
- |
0.5 |
- |
- |
- |
- |
- |
- |
- |
- |
|
2 |
48 |
F |
An |
T4N0Mx |
Int |
- |
52.2 |
16.0 |
4.1 |
1.2 |
2.4 |
0.6 |
8.2 |
- |
- |
- |
13.5 |
1.8 |
- |
- |
|
3 |
58 |
M |
Co/an |
T1N1Mx |
Int |
+ |
68.5 |
14.5 |
4.5 |
- |
3.0 |
- |
3.5 |
2.5 |
1.5 |
0.5 |
- |
1.5 |
- |
- |
|
4 |
48 |
F |
Co/an |
T3N0Mx |
Int |
+ |
62.2 |
15.6 |
10.0 |
3.2 |
0.5 |
- |
6.5 |
1.0 |
- |
0.5 |
0.5 |
- |
- |
- |
|
5 |
24 |
F |
Co/an |
T3N3Mx |
Int |
- |
50.7 |
39.0 |
9.6 |
- |
- |
- |
- |
- |
0.7 |
- |
- |
- |
- |
- |
|
6 |
71 |
F |
An/py |
T2N0Mx |
Dif |
- |
65.0 |
20.0 |
12.0 |
1.0 |
- |
2.0 |
- |
- |
- |
- |
- |
- |
- |
- |
|
7 |
41 |
F |
Co/an/py |
T4NxMx |
Int |
+ |
84.5 |
7.8 |
6.5 |
- |
- |
0.6 |
0.6 |
- |
- |
- |
- |
- |
- |
- |
|
8 |
63 |
F |
Co/an |
T4N3M1 |
Dif |
0 |
67.0 |
25.0 |
3.0 |
2.0 |
- |
1.0 |
- |
- |
- |
- |
1.5 |
- |
- |
0.5 |
|
9 |
68 |
F |
An |
T1N1Mx |
Int |
+ |
70.0 |
11.5 |
4.5 |
3.0 |
2.0 |
- |
4.0 |
1.5 |
1.0 |
0.5 |
2.0 |
- |
- |
- |
|
10 |
76 |
M |
An/py |
T3N1M1 |
Int |
- |
68.0 |
14.0 |
2.0 |
2.0 |
6.0 |
- |
5.0 |
0.5 |
2.5 |
- |
- |
- |
- |
- |
|
11 |
41 |
F |
All |
T3N1M0 |
Dif |
- |
54.5 |
29.5 |
- |
2.0 |
3.5 |
- |
9.0 |
0.5 |
0.5 |
0.5 |
- |
- |
- |
- |
|
12 |
60 |
M |
An |
T3N2Mx |
Int |
0 |
88.0 |
7.0 |
5.0 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
13 |
65 |
M |
Ca/fu |
T3N1Mx |
Int |
0 |
69.0 |
16.0 |
10.5 |
- |
0.5 |
2.0 |
1.0 |
0.5 |
- |
- |
- |
- |
0.5 |
- |
|
14 |
52 |
M |
Co/ca |
T2N1Mx |
Int |
+ |
76.5 |
15.0 |
7.5 |
- |
- |
0.5 |
0.5 |
- |
- |
- |
- |
- |
- |
- |
|
15 |
48 |
M |
Co/an |
T2N1Mx |
Intl |
+ |
54.0 |
24.0 |
1.5 |
5.0 |
5.5 |
2.5 |
6.0 |
1.5 |
- |
- |
- |
- |
- |
- |
|
16 |
52 |
F |
An/py |
T3N1Mx |
Int |
- |
53.4 |
27.0 |
1.6 |
3.2 |
4.2 |
1.6 |
8.0 |
- |
- |
1.0 |
- |
- |
- |
- |
|
17 |
50 |
F |
An/py |
T4N1Mx |
Int |
+ |
63.0 |
19.0 |
4.0 |
2.0 |
0.5 |
1.0 |
7.5 |
- |
2.0 |
1.0 |
- |
- |
- |
- |
|
18 |
47 |
F |
An |
T2N0Mx |
Dif |
- |
65.0 |
17.5 |
9.5 |
1.0 |
2.5 |
1.5 |
1.5 |
1.0 |
- |
- |
0.5 |
- |
- |
- |
|
19 |
74 |
F |
Co/an/py |
T4N1Mx |
Dif |
- |
67.0 |
21.5 |
- |
1.0 |
7.5 |
- |
1.5 |
1.5 |
- |
- |
- |
- |
- |
- |
|
20 |
31 |
M |
Co/an/py |
T3N1Mx |
Dif |
- |
62.7 |
24.3 |
2.7 |
5.5 |
1.6 |
- |
2.7 |
0.5 |
- |
- |
- |
- |
- |
- |
|
|
||||||||||||||||||||
|
† Tumor location: An = antrum; Ca = cardia; Co = corpus; Fu = fundus; Py = pylorus | ‡ TNM pathological staging | §Laurén's classification: Int = Intestinal; Dif = Diffuse | Immunostaining: 0 = not done; (-) without immunoreactivity; (+) with immunoreactivity. |
||||||||||||||||||||
|
Khayat et al. BMC Gastroenterology 2009 9:55 doi:10.1186/1471-230X-9-55 |
||||||||||||||||||||
